File photo

Covid jab maker BioNTech said Monday it would build a factory in Singapore that could produce hundreds of millions of doses of vaccines based on its mRNA technology per year in southeast Asia.

Construction of the manufacturing plant and a regional headquarters in Singapore will start this year, and the site could become operational by 2023, the German company said in a statement.